Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

Share

Orion Pharma AS

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 8 Less Arrow 2 More Arrow 3
Earnings before taxes 5,500 More Arrow 9,691 Less Arrow 1,873
Total assets 25,728 Less Arrow 24,276 Less Arrow 14,933
Current assets 24,750 Less Arrow 23,184 Less Arrow 13,829
Current liabilities 21,506 Less Arrow 13,758 Less Arrow 9,978
Equity capital 4,210 More Arrow 10,502 Less Arrow 4,937
- share capital 790 More Arrow 846 Less Arrow 820

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 16.4% More Arrow 43.3% Less Arrow 33.1%
Turnover per employee
Profit as a percentage of turnover
Return on assets (ROA) 21.4% More Arrow 39.9% Less Arrow 12.6%
Current ratio 115.1% More Arrow 168.5% Less Arrow 138.6%
Return on equity (ROE) 130.6% Less Arrow 92.3% Less Arrow 37.9%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.